Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
80.48B
Market cap80.48B
Price-Earnings ratio
22.38
Price-Earnings ratio22.38
Dividend yield
Dividend yield
Average volume
19.08M
Average volume19.08M
High today
$54.48
High today$54.48
Low today
$53.49
Low today$53.49
Open price
$53.98
Open price$53.98
Volume
15.92M
Volume15.92M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$53.15
52 Week low$53.15

Stock Snapshot

The current Boston Scientific(BSX) stock price is $54.20, with a market capitalization of 80.48B. The stock trades at a price-to-earnings (P/E) ratio of 22.38.

On 2026-05-12, Boston Scientific(BSX) stock traded between a low of $53.49 and a high of $54.48. Shares are currently priced at $54.20, which is +1.3% above the low and -0.5% below the high.

The Boston Scientific(BSX)'s current trading volume is 15.92M, compared to an average daily volume of 19.08M.

During the past year, Boston Scientific(BSX) stock moved between $53.15 at its lowest and $109.50 at its peak.

During the past year, Boston Scientific(BSX) stock moved between $53.15 at its lowest and $109.50 at its peak.

BSX News

Simply Wall St 2d
Boston Scientific Valuation Check After New Atrial Fibrillation And Stroke Prevention Data

Advertisement Clinical data spotlight on cardiac technologies Boston Scientific (BSX) is back in focus after new clinical results for its FARAPULSE PFA and WA...

Boston Scientific Valuation Check After New Atrial Fibrillation And Stroke Prevention Data
Simply Wall St 5d
Boston Scientific Governance Shift Raises Questions On Investor Influence

Boston Scientific (NYSE:BSX) stockholders approved the removal of supermajority voting requirements at a recent shareholder meeting. Shareholders also adopted...

Boston Scientific Governance Shift Raises Questions On Investor Influence
TipRanks 5d
Boston Scientific issues correction for ACCOLADE pacemakers, FDA says

The FDA is aware that Boston Scientific (BSX) has issued a letter to affected customers recommending all ACCOLADE pacemakers and CRT-Ps be corrected prior to co...

Analyst ratings

95%

of 37 ratings
Buy
94.6%
Hold
5.4%
Sell
0%

More BSX News

Nasdaq 5d
BSX June 26th Options Begin Trading

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options become available today, for the June 26th expiration. At Stock Options Channel , our YieldBoo...

BSX June 26th Options Begin Trading
TipRanks 5d
Penumbra Shareholders Approve Merger with Boston Scientific

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.